News & Events

News

All categories

Earnings

Press Release

All years

2021

2020

2019

2018

2017

2016

2015

2014

Affimed Reports Financial Results for Fourth Quarter and Year End 2017

March 20, 2018

Affimed Appoints Dr. Leila Alland as Chief Medical Officer

March 19, 2018

Affimed to Present Data on AFM24 at AACR Annual Meeting 2018

March 15, 2018

Affimed Announces Fourth Quarter and Year End 2017 Financial Results and Corporate Update Conference Call

March 13, 2018

Affimed to Present at the Cowen and Company 38th Annual Health Care Conference

March 8, 2018

Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares

February 15, 2018

Affimed Announces Pricing of Public Offering of Common Stock

February 13, 2018

Affimed Announces Proposed Public Offering of Common Stock

February 12, 2018

Affimed Reports New Data for AFM13 from Two Separate Clinical Trials in Hodgkin and CD30-Positive Lymphomas

February 1, 2018

Affimed Presents Data from Phase 1b Combination Study of AFM13 with Pembrolizumab at ASH

December 11, 2017

Events

All

Scientific

Investors

23Mar

Innate Killer Summit

March 23 - 25, 2021 (virtual)

Webcasts
More events